The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Panbela Therapeutics, Inc.(PINK:PBLA) 
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which...
Share this website to your friends
Panbela Therapeutics . Days Payable Outstanding ttm (DPO)
Panbela Therapeutics . Days Receivable Outstanding ttm (DSO)
Panbela Therapeutics . Op Cashflow Per Share ttm
Panbela Therapeutics . Free Cashflow Per Share ttm
Panbela Therapeutics . Cash Per Share ttm
Panbela Therapeutics . P/S ratio ttm
Panbela Therapeutics . (GAAP) P/E ratio ttm
Panbela Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.